Intensive fasting boosts red blood cells’ immune powers against COVID-19, study finds

Researchers found that short-term intensive fasting enhances the immune function of red blood cells, including their ability to combat SARS-CoV-2, without affecting their oxygen-carrying capacity. The study reveals that this fasting regimen popular in Asia could offer a multifaceted benefit by amplifying the body’s defenses without compromising essential functions.

Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024 – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Study results/Conference 03.06.2024 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz

June 4, 2024

AbbVie wins UK NICE endorsement for subcutaneous Tepkinly in DLBCL

Share this article Tepkinly has received accelerated approval from the FDA and a conditional marketing authorisation from the European Commission as third-line therapy in adult

February 2, 2024

New model predicts 10-year risk of dying from breast cancer

A team of researchers at the University of Oxford, led by the Nuffield Department of Primary Care Health Sciences, have developed a new model that

August 24, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.